MP16-11 JAPANESE PHASE I/II STUDY OF MULTIPEPTIDE-BASED CANCER VACCINE IMA901 AFTER SINGLE-DOSE CYCLOPHOSPHAMIDE IN JAPANESE PATIENTS WITH ADVANCED RENAL CELL CANCER
Author(s) -
Fumiya Hongo,
Natsuki Takaha,
Takashi Ueda,
Kimihiro Yano,
Satoshi Tamada,
Oliver Schoor,
Harpreet SinghJasuja,
Tatsuya Nakatani,
Tsuneharu Miki,
Osamu Ukimura
Publication year - 2017
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2017.02.517
Subject(s) - medicine , tolerability , cancer , cyclophosphamide , clinical trial , phases of clinical research , kidney cancer , oncology , adverse effect , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom